NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

2–3 year stock research →

7626Listed tickers in the SEC universe 4350Issuers with current reporting periods 1430Issuers with both EPS and ROE metrics 2026-11-06Fundamentals evaluated as of

Example screens

Period 1M3M6M1Y5YMAX
Drawing LineCandles
Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

4350 companies match

Showing 2701–2750 of 4350 · page 55/87

Per page 2550100

Companies with a published price series: 4338 of 4350 · Daily EOD closes from the BibaMoney price store (splits reflected, cash dividends not) · 2026-11-06

HYNE NASDAQ

Hoyne Bancorp, Inc.

18.80 +34.29% 5Y

history starts Dec 2025

Combined rank
—
EPS acceleration
—
ROE
0.2%
HYPD NASDAQ

HYPERION DEFI, INC.

3.22 -98.90% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
6.5%
HYPR NASDAQ

Hyperfine, Inc.

0.72 -92.79% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-94.8%
HZO NYSE

MARINEMAX INC

52.76 -0.96% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
0.4%
IAU NYSE

ISHARES GOLD TRUST

72.92 +116.51% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
-413.8 pp
ROE
—
IAUX NYSE

i-80 Gold Corp.

1.39 -33.81% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-118.0%
IBEX NASDAQ

IBEX Ltd

44.73 +238.10% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
27.2%
IBIO NASDAQ

iBio, Inc.

0.77 -99.79% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-38.6%
IBRX NASDAQ

ImmunityBio, Inc.

8.29 +6.42% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
ICHR NASDAQ

ICHOR HOLDINGS, LTD.

38.90 -18.77% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
0.4%
ICUI NASDAQ

ICU MEDICAL INC/DE

163.78 -27.60% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
IDA NYSE

IDACORP INC

147.01 +40.52% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
IDAI NASDAQ

T Stamp Inc

2.82 -88.72% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-327.0%
IDN NASDAQ

Intellicheck, Inc.

2.37 -53.71% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
14.0%
IDT NYSE

IDT CORP

82.02 +51.11% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
23.0%
IESC NASDAQ

IES Holdings, Inc.

205.96 +758.17% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
43.3 pp
ROE
—
IGC NYSE

IGC Pharma, Inc.

0.19 -85.50% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
IHRT NASDAQ

iHeartMedia, Inc.

1.84 -90.62% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
IIIV NASDAQ

i3 Verticals, Inc.

17.58 -5.74% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
3.0%
IMA NASDAQ

ImageneBio, Inc.

4.10 -97.61% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-36.9%
IMKTA NASDAQ

INGLES MARKETS INC

84.11 +9.55% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
6.2%
IMMR NASDAQ

IMMERSION CORP

7.20 +19.80% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
3.5%
IMNM NASDAQ

Immunome Inc.

18.21 -3.91% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-48.4%
IMNN NASDAQ

Imunon, Inc.

0.91 -99.40% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-351.3%
IMRX NASDAQ

Immuneering Corp

3.74 -83.47% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-39.4%
IMUX NASDAQ

IMMUNIC, INC.

7.51 -91.20% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-87.4%

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-05. Source: FRED / Federal Reserve.